We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Eases Trial Requirements for Blood Thinner Biosimilars
EMA Eases Trial Requirements for Blood Thinner Biosimilars
The development process for biosimilar blood thinners no longer requires a comparative clinical trial, according to new guidance from the European Medicines Agency.